UnknownNCT04076527

Prospective, Multicenter Cohort Study on Primary Biliary Cholangitis

Studying Primary biliary cholangitis

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: University of Leipzig
Principal Investigator: Thomas Berg, Prof.Dr.
University of Leipzig
Intervention: UDCA(drug)
Enrollment: 1200 target
Eligibility: 18 years · All sexes
Timeline: 2019 – 2024

Study locations (30)

University Hospital Aachen, Aachen, Germany
Charité - Campus Benjamin Franklin, Berlin, Germany
Charité-Campus Virchow-Klinikum, Berlin, Germany
Internal Practice, Berlin, Germany
Liver Center Checkpoint, Berlin, Germany
MVZ Gastroenterology, Berlin, Germany
Hospital Chemnitz, Chemnitz, Germany
University Hospital Cologne, Cologne, Germany
Internal Practice, Dornstadt, Germany
MVZ Düsseldorf, Düsseldorf, Germany
University hospital Düsseldorf, Düsseldorf, Germany
University Hospital Erlangen, Erlangen, Germany
St. Josef- Hospital Kupferdreh, Essen, Germany
University Hospital Essen, Essen, Germany
Internal Practice, Frankfurt, Germany
+15 more locations on ClinicalTrials.gov

Collaborators

RWTH Aachen University · Zentrum für Klinische Studien Leipzig · Intercept Pharma Europe Limited (IPEL) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · University Hospital Erlangen · Medical care center for Gastroenterology, Berlin · Institute for Interdisciplinary Medicine, Hamburg · Leberhilfe Projekt gUG, Cologne · Hannover Medical School

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04076527 on ClinicalTrials.gov

Other trials for Primary biliary cholangitis

Additional recruiting or active studies for the same condition.

See all trials for Primary biliary cholangitis →

← Back to all trials